Elevated Serum IGFBP-2 and CTGF Levels Are Associated with Disease Activity in Patients with Dermatomyositis

Figure 1

Serum levels of IGFBPs detected by ELISA in HCs and patients with DM. (a) IGFBP-1. (b) IGFBP-2. (c) IGFBP-3. (d) IGFBP-4. (e) IGFBP-6. (f) CTGF. Data are expressed as median (quartile). HC: healthy control; DM: dermatomyositis.

(a)

(b)

(c)

(d)

(e)

(f)